Drug Master Files for: Covidien
✉ Email this page to a colleague
Covidien Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
14004 | I | II | 2/26/1999 | MALLINCKRODT INC THE PHARMACEUTICALS BUSINESS OF COVIDIEN | PROPOXYPHENE HYDROCHLORIDE USP POWDER (E SUB) |
17752 | I | II | 9/30/2004 | MALLINCKRODT INC THE PHARMACEUTICALS BUSINESS OF COVIDIEN | MORPHINE ALKALOID, CODE 1547 |
18834 | I | II | 9/30/2005 | MALLINCKRODT INC THE PHARMACEUTICALS BUSINESS OF COVIDIEN | HYDROMORPHONE BASE |
21820 | I | II | 7/17/2008 | MALLINCKRODT INC THE PHARMACEUTICALS BUSINESS OF COVIDIEN | 6-BETA-NALTREXOL HYDROCHLORIDE |
8064 | I | II | 5/5/1989 | MALLINCKRODT INC THE PHARMACEUTICALS BUSINESS OF COVIDIEN | SODIUM IODIDE I-123 |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information